-
2
-
-
8044224686
-
Leukemias and cancers following iodine-131 administration for thyroid cancer
-
de Vathaire F, Schlumberger M, Delisle MJ, Francese C, Challeton C, de la Genardiere E, Meunier F, Parmentier C, Hill C, Sancho Gamier H (1997) Leukemias and cancers following iodine-131 administration for thyroid cancer. Br J Cancer 75:734-739
-
(1997)
Br J Cancer
, vol.75
, pp. 734-739
-
-
De Vathaire, F.1
Schlumberger, M.2
Delisle, M.J.3
Francese, C.4
Challeton, C.5
De La Genardiere, E.6
Meunier, F.7
Parmentier, C.8
Hill, C.9
Sancho Gamier, H.10
-
3
-
-
0022644803
-
The long-term hazards of the treatment of thyroid cancer with radioiodine
-
Edmonds CJ, Smith T (1986) The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 59:45-51
-
(1986)
Br J Radiol
, vol.59
, pp. 45-51
-
-
Edmonds, C.J.1
Smith, T.2
-
4
-
-
0031026450
-
Aetiology of acute leukaemia
-
Greaves MF (1997) Aetiology of acute leukaemia. Lancet 349:344-349
-
(1997)
Lancet
, vol.349
, pp. 344-349
-
-
Greaves, M.F.1
-
6
-
-
0028935735
-
Cancer in iodine-131 exposed patients
-
Hall P, Holm LE (1992) Cancer in iodine-131 exposed patients. J Endocrinol Invest 18:147-149
-
(1992)
J Endocrinol Invest
, vol.18
, pp. 147-149
-
-
Hall, P.1
Holm, L.E.2
-
7
-
-
0026655515
-
Leukemia incidence after iodine-131 exposure
-
Hall P, Boice JD, Berg G, Bjelkengren G, Ericson UB, Hallquist A, Lidberg M, Lundell G, Mattson A, Tennvall J, Wiklund K, Holm LE (1992) Leukemia incidence after iodine-131 exposure. Lancet 340:1-4
-
(1992)
Lancet
, vol.340
, pp. 1-4
-
-
Hall, P.1
Boice, J.D.2
Berg, G.3
Bjelkengren, G.4
Ericson, U.B.5
Hallquist, A.6
Lidberg, M.7
Lundell, G.8
Mattson, A.9
Tennvall, J.10
Wiklund, K.11
Holm, L.E.12
-
8
-
-
34548007833
-
-
Holm LE, Hall P, Wiklund K, Lundell G, Berg G, Bjelkengren G, Cederquist E, Ericson UB, Hallquist A, Larsson LG, et al (1995) Cancer risk after iodine-131 therapy for hyperthyroidism 86:1026-1027
-
(1995)
Cancer Risk after Iodine-131 Therapy for Hyperthyroidism
, vol.86
, pp. 1026-1027
-
-
Holm, L.E.1
Hall, P.2
Wiklund, K.3
Lundell, G.4
Berg, G.5
Bjelkengren, G.6
Cederquist, E.7
Ericson, U.B.8
Hallquist, A.9
Larsson, L.G.10
-
9
-
-
0019846632
-
The role of nuclear medicine in the treatment of hyperthyroidism and well-differentiated thyroid adenocarcinoma
-
Maxon HR, Thomas SR, Che IW (1981) The role of nuclear medicine in the treatment of hyperthyroidism and well-differentiated thyroid adenocarcinoma. Clin Nucl Med 6:87-97
-
(1981)
Clin Nucl Med
, vol.6
, pp. 87-97
-
-
Maxon, H.R.1
Thomas, S.R.2
Che, I.W.3
-
10
-
-
0023680693
-
A rational approach to the treatment of hyperthyroidism
-
Peele ME, Wartofsky L (1988) A rational approach to the treatment of hyperthyroidism. Compr Ther 14:34-46
-
(1988)
Compr Ther
, vol.14
, pp. 34-46
-
-
Peele, M.E.1
Wartofsky, L.2
-
11
-
-
0028875537
-
131I treatment for thyroid carcinoma: A report of two cases and review of the literature
-
131I treatment for thyroid carcinoma: a report of two cases and review of the literature. Clin Endocrinol 43:651-654
-
(1995)
Clin Endocrinol
, vol.43
, pp. 651-654
-
-
Shimon, I.1
Kneller, A.2
Olchovsky, D.3
-
12
-
-
0022379711
-
The action of oncogenes in the cytoplasm and nucleus
-
Weinberg RA (1985) The action of oncogenes in the cytoplasm and nucleus. Science 230:770-776
-
(1985)
Science
, vol.230
, pp. 770-776
-
-
Weinberg, R.A.1
-
13
-
-
0023264823
-
-
Yoosufani Z, Slavin JD, Hellman RM, Sethi SS, Spencer RP (1987) J Nucl Med 28:1348-1350
-
(1987)
J Nucl Med
, vol.28
, pp. 1348-1350
-
-
Yoosufani, Z.1
Slavin, J.D.2
Hellman, R.M.3
Sethi, S.S.4
Spencer, R.P.5
|